Biologics Formulation Development and Drug Delivery Forum

06/06/2018 - 08/06/2018 Amsterdam, Netherlands

This marcus evans forum will feature these existing key problems confronting formulation scientists and assist them with a better experiment protocol to ensure quality processes aligned with health authorities requirements, robust and rational methodology to minimise failure risks. The delegates will benefit from experienced case study and understand how to improve formulation stability, preventing aggregation, develop high-concentration forms; they will also learn how to use predictive and analytical methods in order to understand the behaviour and evolution of proteins under different stresses and help scientists characterising proteins and different components of the formulation. They will also apprehend the manufacturing and scale up challenges, looking at compatibility problems, lyophilisation issues, and consider the different possibilities offered for drug delivery, keeping in mind the crucial need for improving comfort and safety to patient.

 

Attending this premier marcus evans conference will enable you to:

  • Improve the design of biological formulation with automated and high-throughput solutions
  • Integrate QbD processes in biological drug development
  • Enhance stability process controlling aggregation
  • Improve characterization with efficient analytical tools
  • Discuss the regulatory environment around biological drug development
  • Address the challenges of scale up, lyophilisation and tech transfer processes
  • Exchange on the recent improvement in drug delivery for various biological molecules and vaccines

 

Learn from key practical case studies:

  • Janssen discussing impact of process parameters product stability
  • Abbvie designing bioformulation with HTS and lab automation
  • Boehringer-Ingelheim looking at current issues with polysorbate
  • University of Kent showing innovative methods within transdermal delivery